CytoDyn Inc. (CYDY) Plans to File IND for Clinical Trial of PRO 140 in Colon Carcinoma Patients following Significant Preclinical Results
PRO 140 has been shown effective in inhibiting the growth of a human colon carcinoma cell line (SW480) in a…
PRO 140 has been shown effective in inhibiting the growth of a human colon carcinoma cell line (SW480) in a…
Revenues up by 54 percent in second quarter Gross profit climbs by 17 percent Zero Cost Program sign-ups drive asset…
Providing first and only comprehensive card processing operation in the cannabis industry Diversifying commitment beyond a payment solution and increasing…
GPS SmartSole® selected by George Mason University for groundbreaking study to link movement patterns of dementia patients with progression of…
GPS technology-focused holding company GTX Corp (OTC: GTXO) this morning provided a summary of the company’s activities and achievements during…
Sky Mids Technologies’ transactional book of business, capable of processing more than $1 billion annually, will be added selectively to…
Marijuana Company of America Inc. (OTC: MCOA), along with joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF),…
Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that it…
Diverse holdings company DPW Holdings (NYSE American: DPW) this morning submitted its quarterly report on Form 10-Q reporting financial results…
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) this morning announced that it has completed an agreement with the Ontario Cannabis…